11 US Senators have written to the Attorney General Eric Holder and the newly-confirmed Heath and Human Services Secretary Kathleen Sebelius to call for the federal administration to end delays in a rule to simplify the electronic prescribing of medicines.
The problem was originally caused by the requirement of the Drug Enforcement Administration that certain restricted active ingredients should be prescribed with a physical paper trail (Marketletters passim). This meant that physicians would not be able to switch over to a fully-paperless scrip system and jeopardize the hoped for savings of scrapping paper prescriptions.
According to one of the letter's authors, Senator Sheldon Whitehouse (Democrat, Rhode Island), only 18% of the USA's physicians currently use e-prescribing. In addition to an estimated annual $20.0-billion saving from fewer adverse events caused by prescribing errors, the Senators argue that the technology is a "logical gateway" towards a comprehensive countrywide patient record program, which advocates claim would save $346.0 billion per year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze